Maccura Biotechnology Co Ltd - Class A

SZSE:300463 (China)   Class A
Â¥ 13.81 (+0.36%) May 8
26.51
P/B:
1.31
Market Cap:
Â¥ 8.46B ($ 1.17B)
Enterprise V:
Â¥ 8.18B ($ 1.13B)
Volume:
5.52M
Avg Vol (2M):
5.33M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Maccura Biotechnology Co Ltd ( ) from 2015 to May 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Maccura Biotechnology stock (SZSE:300463) PE ratio as of May 08 2024 is 26.51. More Details

Maccura Biotechnology Co Ltd (SZSE:300463) PE Ratio (TTM) Chart

To

Maccura Biotechnology Co Ltd (SZSE:300463) PE Ratio (TTM) Historical Data

Total 1178
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Maccura Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-08 26.5 2024-02-28 24.4
2024-05-07 26.4 2024-02-27 25.3
2024-05-06 26.1 2024-02-26 24.8
2024-04-30 25.2 2024-02-23 24.6
2024-04-29 24.8 2024-02-22 24.4
2024-04-26 24.4 2024-02-21 24.3
2024-04-25 24.1 2024-02-20 24.3
2024-04-24 23.3 2024-02-19 24.3
2024-04-23 23.1 2024-02-08 24.6
2024-04-22 22.9 2024-02-07 23.5
2024-04-19 22.4 2024-02-06 22.1
2024-04-18 22.6 2024-02-05 20.2
2024-04-17 22.9 2024-02-02 21.7
2024-04-16 21.9 2024-02-01 22.9
2024-04-15 22.8 2024-01-31 23.0
2024-04-12 23.6 2024-01-30 24.4
2024-04-11 23.9 2024-01-29 24.9
2024-04-10 24.2 2024-01-26 25.4
2024-04-09 24.7 2024-01-25 25.8
2024-04-08 24.1 2024-01-24 24.9
2024-04-03 24.9 2024-01-23 24.6
2024-04-02 25.0 2024-01-22 24.7
2024-04-01 25.2 2024-01-19 26.2
2024-03-29 24.3 2024-01-18 26.4
2024-03-28 24.1 2024-01-17 26.7
2024-03-27 24.5 2024-01-16 27.6
2024-03-26 25.1 2024-01-15 27.9
2024-03-25 25.0 2024-01-12 28.0
2024-03-22 25.7 2024-01-11 28.2
2024-03-21 26.6 2024-01-10 28.0
2024-03-20 26.7 2024-01-09 28.1
2024-03-19 26.5 2024-01-08 28.0
2024-03-18 26.9 2024-01-05 28.9
2024-03-15 26.3 2024-01-04 29.4
2024-03-14 26.0 2024-01-03 29.3
2024-03-13 26.2 2024-01-02 29.4
2024-03-12 25.8 2023-12-29 29.5
2024-03-11 25.8 2023-12-28 29.3
2024-03-08 24.4 2023-12-27 24.2
2024-03-07 24.2 2023-12-26 23.9
2024-03-06 24.7 2023-12-25 24.2
2024-03-05 25.0 2023-12-22 24.3
2024-03-04 25.4 2023-12-21 24.8
2024-03-01 25.3 2023-12-20 25.0
2024-02-29 25.0 2023-12-19 25.0

Maccura Biotechnology Co Ltd (SZSE:300463) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.